ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234449.2	Gefitinib	Bladder urothelial carcinoma	0.032738817	Resistant
ENSG00000234449.2	Gefitinib	Skin cutaneous melanoma	0.038927174	Resistant